drug combination

452 articles

Research
November 6, 2018 • 2 Min

Immunotherapy Combination Plus Radiation for Pancreatic Cancer

Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.

Research
March 10, 2017 • 2 Min

Maintenance Chemotherapy for Stable Metastatic Pancreatic Cancer

A clinical trial tests the diabetes drug metformin and transplant rejection preventative rapamycin to act as maintenance chemotherapy for pancreatic cancer.

Research
December 15, 2021 • 3 Min

Claudin May Be the Next Big Target in Pancreatic Cancer Treatment

Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.

Research
August 10, 2016 • 2 Min

Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer

A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.

Research
June 17, 2022 • 3 Min

New Gene Inhibitor Drug for Patients with MTAP-Deleted Tumors

A new trial targets patients with advanced solid tumors, including pancreatic cancer, with an MTAP-deletion genetic mutation.

Research
September 21, 2023 • 2 Min

Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer

In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.

Clinical Trials
April 10, 2018 • 2 Min

Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors

In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).

Research
August 12, 2022 • 2 Min

Hypertension Drug as Part of First-Line Treatment for Unresectable Pancreatic Cancer

Researchers are testing if the addition of a hypertension drug to standard treatment will be more effective for advanced pancreatic cancer.

Research
October 16, 2018 • 2 Min

Finding a Safe Dose of a New Drug for Some Types of Solid Tumors

LMB-100 is a lab-created protein that targets mesothelin. It is being tested against pancreatic cancer and other solid tumors in a clinical trial.

Survivor Stories
June 20, 2017 • 4 Min

The Relatively New Procedure of Irreversible Electroporation Has Given Me Time

When chemotherapy and radiation stopped working, Leslie Wineberg was glad to qualify for irreversible electroporation (IRE).

Research
August 30, 2017 • 2 Min

More Effective Focused Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer

A clinical trial tests whether adding Zometa makes chemotherapy and stereotactic body radiation therapy (SBRT) more effective against pancreatic cancer.

Research
June 23, 2017 • 4 Min

Targeted Therapy for Pancreatic Cancer

Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.

Survivor Stories
January 19, 2017 • 3 Min

I Have Pancreatic Cancer; It Does Not Have Me

Bill Shrieves was ready to start a clinical trial for pancreatic cancer when it was found to have spread. He was successfully treated with FOLFIRINOX.

Research
December 13, 2017 • 2 Min

Treating Tumors Before Pancreatic Cancer Surgery

Can neoadjuvant treatment such as chemoradiation make pancreatic cancer removal surgery more effective? That is the question asked by this clinical trial.

Research
May 12, 2020 • 7 Min

Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint

Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.